10-24275902-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019590.5(KIAA1217):​c.354+55993C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.914 in 428,112 control chromosomes in the GnomAD database, including 180,223 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.94 ( 67506 hom., cov: 32)
Exomes 𝑓: 0.90 ( 112717 hom. )

Consequence

KIAA1217
NM_019590.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.403

Publications

5 publications found
Variant links:
Genes affected
KIAA1217 (HGNC:25428): (KIAA1217) Predicted to be involved in embryonic skeletal system development. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
MIR603 (HGNC:32859): (microRNA 603) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.967 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIAA1217NM_019590.5 linkc.354+55993C>T intron_variant Intron 2 of 20 ENST00000376454.8 NP_062536.2 Q5T5P2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIAA1217ENST00000376454.8 linkc.354+55993C>T intron_variant Intron 2 of 20 1 NM_019590.5 ENSP00000365637.3 Q5T5P2-1

Frequencies

GnomAD3 genomes
AF:
0.940
AC:
143025
AN:
152122
Hom.:
67472
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.975
Gnomad AMI
AF:
0.888
Gnomad AMR
AF:
0.942
Gnomad ASJ
AF:
0.923
Gnomad EAS
AF:
0.782
Gnomad SAS
AF:
0.724
Gnomad FIN
AF:
0.973
Gnomad MID
AF:
0.953
Gnomad NFE
AF:
0.943
Gnomad OTH
AF:
0.925
GnomAD4 exome
AF:
0.899
AC:
248130
AN:
275872
Hom.:
112717
AF XY:
0.883
AC XY:
136641
AN XY:
154666
show subpopulations
African (AFR)
AF:
0.974
AC:
6525
AN:
6698
American (AMR)
AF:
0.941
AC:
17242
AN:
18326
Ashkenazi Jewish (ASJ)
AF:
0.920
AC:
4854
AN:
5274
East Asian (EAS)
AF:
0.787
AC:
8725
AN:
11090
South Asian (SAS)
AF:
0.735
AC:
35962
AN:
48916
European-Finnish (FIN)
AF:
0.975
AC:
25735
AN:
26402
Middle Eastern (MID)
AF:
0.909
AC:
2144
AN:
2358
European-Non Finnish (NFE)
AF:
0.939
AC:
135881
AN:
144690
Other (OTH)
AF:
0.913
AC:
11062
AN:
12118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1159
2318
3478
4637
5796
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.940
AC:
143110
AN:
152240
Hom.:
67506
Cov.:
32
AF XY:
0.938
AC XY:
69788
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.975
AC:
40509
AN:
41554
American (AMR)
AF:
0.941
AC:
14388
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.923
AC:
3206
AN:
3472
East Asian (EAS)
AF:
0.782
AC:
4014
AN:
5130
South Asian (SAS)
AF:
0.724
AC:
3488
AN:
4820
European-Finnish (FIN)
AF:
0.973
AC:
10336
AN:
10620
Middle Eastern (MID)
AF:
0.946
AC:
278
AN:
294
European-Non Finnish (NFE)
AF:
0.943
AC:
64142
AN:
68032
Other (OTH)
AF:
0.918
AC:
1939
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
422
843
1265
1686
2108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
906
1812
2718
3624
4530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.945
Hom.:
13779
Bravo
AF:
0.942
Asia WGS
AF:
0.756
AC:
2633
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.91
DANN
Benign
0.32
PhyloP100
-0.40
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10764458; hg19: chr10-24564831; API